Ligand validation:3P0E

BAU: 1-((2-HYDROXYETHOXY)METHYL)-5-BENZYLPYRIMIDINE-2,4(1H,3H)-DIONE

BAU is a Ligand Of Interest in 3P0E designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3P0E_BAU_C_400	80%	24%	0.115	0.966	1.17	2.05	2	4	2	0	100%	1
3P0E_BAU_A_400	78%	23%	0.112	0.956	1.32	1.99	2	5	2	0	100%	1
3P0E_BAU_F_400	77%	25%	0.119	0.959	1.37	1.85	1	4	0	0	100%	1
3P0E_BAU_E_400	76%	33%	0.13	0.967	1.02	1.73	1	5	0	0	100%	1
3P0E_BAU_D_400	72%	22%	0.134	0.96	1.32	2.08	1	4	2	0	100%	1
3P0E_BAU_B_400	66%	27%	0.153	0.96	1.49	1.6	2	3	0	0	100%	1
3P0F_BAU_A_400	88%	16%	0.096	0.973	1.35	2.46	1	4	0	0	100%	1
1U1C_BAU_F_5051	73%	7%	0.12	0.948	2.53	2.56	10	5	0	0	100%	1
3EUF_BAU_A_400	67%	8%	0.133	0.942	1.19	3.51	2	7	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.